TP53 and breast cancer: Breast cancer patients of African ancestry demonstrate more TP53 alterations and fewer PIK3CA alterations6,8, and Nigerian HR+ /HER2− tumors are characterized by increased homologous recombination deficiency (HRD) signature8.